Search results
Recursion (RXRX) Up on Completing REC-994 Study Enrollment
Zacks via Yahoo Finance· 11 months agoRecursion RXRX announced full patient enrollment in its phase II SYCAMORE study evaluating REC-994...
Medicare’s push to improve chronic care attracts businesses, but not many doctors
Fortune via Yahoo Finance· 4 weeks agoCarrie Lester looks forward to the phone call every Thursday from her doctors’ medical assistant,...
Health calendar for Sept. 5, 2023
Florida Today via Yahoo News· 8 months agoUpcoming Diabetic Education, Lunch & Learn Seminar. Thursday, Sept. 7, from 11:30 a.m. to 1 p.m. at One Senior Place, 8085 Spyglass Hill Road, Viera, FL...
How a tiny device could make a big impact on heart disease in Memphis
The Commercial Appeal via Yahoo News· 7 months agoMary Crump, a 52-year-old property manager, had an unrelenting fatigue yet could not sleep. "When I...
Health calendar: Oct. 25, 2022
Florida Today via Yahoo News· 2 years agoSupport local journalism. A digital subscription is incredibly affordable and makes you the most informed person around. Click here and subscribe today....
Where Will Recursion Pharmaceuticals Be in 5 Years?
Motley Fool via Yahoo Finance· 1 month agoAs a biotech that's planning to go big on artificial intelligence (AI) for drug development, Recursion Pharmaceuticals (NASDAQ: RXRX) is a decidedly...